Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Concurrent Chemo-radiotherapy for Locally Advanced NSCLC
NCT01211002Phase 4Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01211002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211002.